Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Guide to Neurotoxic Animal Models of Parkinson's Disease
Kim Tieu
Cold Spring Harbor Perspectives in Medicine (2011) Vol. 1, Iss. 1, pp. a009316-a009316
Open Access | Times Cited: 442

Showing 26-50 of 442 citing articles:

Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson’s disease
Georgia Kouroupi, Era Taoufik, Ioannis S. Vlachos, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 18
Open Access | Times Cited: 137
Microglial Implication in Parkinson’s Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions?
Cynthia Lecours, Maude Bordeleau, Léo Cantin, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 137
Metformin rescues Parkinson’s disease phenotypes caused by hyperactive mitochondria
Danielle E. Mor, Salman Sohrabi, Rachel Kaletsky, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 42, pp. 26438-26447
Open Access | Times Cited: 135
Enteric nervous system manifestations of neurodegenerative disease
Alcmène Chalazonitis, Meenakshi Rao
Brain Research (2018) Vol. 1693, pp. 207-213
Open Access | Times Cited: 125
An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition
Andrea Terron, Anna Bal‐Price, Alicia Paini, et al.
Archives of Toxicology (2017) Vol. 92, Iss. 1, pp. 41-82
Open Access | Times Cited: 105
Animal Models of Parkinson’s Disease
Elena A. Konnova, Maria Swanberg
Codon Publications eBooks (2018), pp. 83-106
Open Access | Times Cited: 105
Genetically modified pig models for neurodegenerative disorders
Ida E. Holm, Aage Kristian Olsen Alstrup, Yonglun Luo
The Journal of Pathology (2015) Vol. 238, Iss. 2, pp. 267-287
Open Access | Times Cited: 104
MPTP‐induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF‐TrkB pathway
Guoqi Zhu, Junyao Li, Ling He, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 9, pp. 2354-2368
Open Access | Times Cited: 103
Neuroprotective effects of fingolimod in mouse models of Parkinson's disease
Peng Zhao, Xiaoxia Yang, Liu Yang, et al.
The FASEB Journal (2016) Vol. 31, Iss. 1, pp. 172-179
Closed Access | Times Cited: 103
Activation of the mitochondrial unfolded protein response promotes longevity and dopamine neuron survival in Parkinson’s disease models
Jason Cooper, Emily Machiela, Dylan J. Dues, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 98
mTOR Signaling in Parkinson’s Disease
Ai-ping Lan, Jun Chen, Yuliang Zhao, et al.
NeuroMolecular Medicine (2016) Vol. 19, Iss. 1, pp. 1-10
Closed Access | Times Cited: 97
The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease
Birgit Liss, Jörg Striessnig
The Annual Review of Pharmacology and Toxicology (2019) Vol. 59, Iss. 1, pp. 263-289
Closed Access | Times Cited: 95
Disease model organism for Parkinson disease: Drosophila melanogaster
Binod Aryal, Youngseok Lee
BMB Reports (2019) Vol. 52, Iss. 4, pp. 250-258
Open Access | Times Cited: 94
Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long‐Standing Model
Anderson H.F.F. Leão, Aldair J. Sarmento‐Silva, José R. Santos, et al.
Brain Pathology (2015) Vol. 25, Iss. 4, pp. 377-390
Open Access | Times Cited: 93
The Pathology of Parkinson’s Disease and Potential Benefit of Dietary Polyphenols
Sunisha Aryal, Taylor Skinner, Bronwyn Bridges, et al.
Molecules (2020) Vol. 25, Iss. 19, pp. 4382-4382
Open Access | Times Cited: 84
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
Julia Benkert, Simon Heß, Shoumik Roy, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 82
Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson’s Disease
Ikuko Miyazaki, Nami Isooka, Fuminori Imafuku, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3254-3254
Open Access | Times Cited: 80
Human α-synuclein overexpression in a mouse model of Parkinson’s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation
Osama F. Elabi, Abderahim Gaceb, R. Carlsson, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 80
Cell models for Alzheimer’s and Parkinson’s disease: At the interface of biology and drug discovery
Sandra Cetin, Damijan Knez, Stanislav Gobec, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112924-112924
Open Access | Times Cited: 42
6PPD-quinone exposure induces neuronal mitochondrial dysfunction to exacerbate Lewy neurites formation induced by α-synuclein preformed fibrils seeding
Jiacheng Fang, Xiaoxiao Wang, Guodong Cao, et al.
Journal of Hazardous Materials (2023) Vol. 465, pp. 133312-133312
Closed Access | Times Cited: 32
Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease from Mice to Human
Martina Montanari, Paola Imbriani, Paola Bonsi, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1560-1560
Open Access | Times Cited: 30
Cognitive heterogeneity in Parkinson’s disease: A mechanistic view
Marc Cárceles-Cordon, Dan Weintraub, Alice Chen‐Plotkin
Neuron (2023) Vol. 111, Iss. 10, pp. 1531-1546
Open Access | Times Cited: 26
Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy
Kristina Lau, Rebecca Kotzur, Franziska Richter
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Genetically modified non-human primate models for research on neurodegenerative diseases
Ming-Tian Pan, Han Zhang, Xiao‐Jiang Li, et al.
动物学研究 (2024) Vol. 45, Iss. 2, pp. 263-274
Open Access | Times Cited: 10
6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson's disease models via anti-neuroinflammation
Gunhyuk Park, Hyo Geun Kim, Mi Sun Ju, et al.
Acta Pharmacologica Sinica (2013) Vol. 34, Iss. 9, pp. 1131-1139
Open Access | Times Cited: 101

Scroll to top